Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 11, 2021 08:30 ET | Source: Rockwell Medical, Inc.

Rockwell Medical Submits Investigational New Drug Application with FDA for its Proposed Clinical Trial of FPC as a Treatment for Iron Deficiency Anemia in Patients Receiving Home Infusion

WIXOM, Mich., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management...
November 08, 2021 07:00 ET | Source: Rockwell Medical, Inc.

Rockwell Medical, Inc. to Report Third Quarter 2021 Financial and Operating Results on November 15, 2021

WIXOM, Mich., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management...
November 04, 2021 16:01 ET | Source: Rockwell Medical, Inc.

Rockwell Medical Presents Triferic® Real World Evidence Update at ASN Kidney Week 2021

-Results from pilot observational analysis demonstrate maintenance of hemoglobin and reduction of total IV iron requirement in adult patients on Triferic receiving chronic hemodialysis- -Findings...
September 09, 2021 09:52 ET | Source: Rockwell Medical, Inc.

Rockwell Medical, Inc. to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

WIXOM, Mich., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management...
August 19, 2021 16:00 ET | Source: Rockwell Medical, Inc.

Rockwell Medical, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

WIXOM, Mich., Aug. 19, 2021 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutical company dedicated to transforming the treatment of...
August 16, 2021 16:09 ET | Source: Rockwell Medical, Inc.

Rockwell Medical, Inc. Provides Second Quarter 2021 Financial and Operational Update

-Entered into exclusive license agreement with Drogsan Pharmaceuticals for the rights to commercialize Triferic® in Turkey- -Extended multi-year distribution agreement with Nipro Medical for dialysis...
July 29, 2021 07:00 ET | Source: Rockwell Medical, Inc.

Rockwell Medical, Inc. to Report Second Quarter 2021 Financial and Operating Results on August 16, 2021

WIXOM, Mich., July 29, 2021 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management...
June 28, 2021 07:00 ET | Source: Rockwell Medical, Inc.

Rockwell Medical, Inc. Files Pre-IND Meeting Request with FDA for its Proposed Clinical Trial of FPC as a Treatment for Iron Deficiency Anemia in Patients Receiving Home Infusion

WIXOM, Mich., June 28, 2021 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management...
June 11, 2021 12:20 ET | Source: Rockwell Medical, Inc.

Rockwell Medical Announces Extension of Multi-Year Distribution Agreement with Nipro Medical Corporation for Dialysis Concentrates

WIXOM, Mich., June 11, 2021 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management...
June 08, 2021 07:00 ET | Source: Rockwell Medical, Inc.

Rockwell Medical and Drogsan Pharmaceuticals Enter into Exclusive License Agreement for the Rights to Commercialize Triferic® in Turkey

WIXOM, Mich. and ANKARA, Turkey, June 08, 2021 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right